SAN DIEGO, Dec. 11, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced November as the largest-ever (unaudited) sales month in its history. Subsidiaries Kannaway® and Phyto Animal Health have also booked their largest-ever (unaudited) sales month in their history in November of 2018. The company has also reached major milestones in its business operations.
“We are proud to announce that we had such great success in November,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “There is significant change and progress occurring throughout the industry and we are happy to be at the forefront of it.”
Medical Marijuana, Inc. and its subsidiaries experienced many accomplishments in November, including subsidiary Kannaway® hosting its European Grand Opening in Prague with over 2,000 attendees and releasing a new Pure Liquid Flavored Trio as well as subsidiary Phyto Animal Health signing a distribution agreement with Mr. Checkout, a company that often helps bring Shark Tank innovations to shelves.
“In November, Kannaway furthered the company’s international expansion efforts by hosting our largest event in company history in Prague,” said Medical Marijuana, Inc. COO Blake Schroeder. “We accredit much of our success to this event in addition to the great work we’ve been doing in the U.S. to expand our product offering.”
Accomplishments also include Dr. Titus speaking at a conference hosted by Direct Selling News, the company exhibiting at the Marijuana Business Conference in Las Vegas, as well as the company obtaining positive news coverage in several national and international news outlets including Yahoo Finance, LA Times, Denver Post, AP, Benzinga, Green Market Report, Forbes, Dallas Observer, Entrepreneur, Cheddar, The Street, and many more.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer